CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
about
Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarctionCXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in miceDistinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patientsExpression of a retinoic acid signature in circulating CD34 cells from coronary artery disease patients.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart.Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells.Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast CancerThe myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis.Angiogenesis following cell injection is induced by an excess inflammatory response coordinated by bone marrow cells.Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice.Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression.SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells.Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury.VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells.The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy.Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery DiseaseProgenitor Cells and Clinical Outcomes in Patients With Heart Failure.Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.Age and Human Regenerative Capacity Impact of Cardiovascular Risk FactorsCirculating endothelial progenitor cells are not affected by acute systemic inflammation.Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function.Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction.Stromal cell derived factor-1α promotes C-Kit+ cardiac stem/progenitor cell quiescence through casein kinase 1α and GSK3β.Sex Differences in Circulating Progenitor Cells.Circulating progenitor cells in patients with familial hypercholesterolemia.Association of circulating progenitor cells with angiotensin II in newly diagnosed hypertensive patients.Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.Myocardial Ischemia and Mobilization of Circulating Progenitor Cells.
P2860
Q24314350-1E2D877A-2373-4E5F-8C12-D8ED3E103E81Q28254272-68F87653-894B-4900-A3A9-3BB2097940E8Q28751480-C556EFEF-A1D1-4E2C-B6FE-CCED7E99A84BQ33611450-C3A973E4-9751-4513-BA89-22EE10CCFFFBQ33745962-800D64FA-32C0-4014-9F30-1776CFF03117Q33818848-9586AEC2-2E5C-4D41-ABAA-E657D5AEFAA3Q34105446-B91F1678-614E-43A1-8790-B9394B30F86DQ34273051-E2F4F18B-6004-414E-9CD8-5809EB281A83Q34356918-54393C57-5DC2-447D-8DAB-5202D0F8959EQ34360213-6A7689EE-B921-4DDE-8996-2CAED60109B1Q34475130-7DC7D750-7293-46A1-A8A9-24222C444075Q34531894-CD0ACB98-4F95-4502-8F66-C580396B1CF5Q35102931-1E9F4313-4511-47EF-A598-BFEC513712E9Q35501916-DF8BC463-9D13-446E-9BFD-D6DBC7FC2244Q35549922-CEB41D4B-A2A2-4FEE-9D96-09EB2D51364FQ35633590-16329DB7-5628-43C0-8953-B52DB7D8EA7FQ36008423-AF71E157-91FF-48F6-AF08-A148273583AFQ36055443-833593E9-5123-4CBB-AFA0-F995DCAC77F3Q36469490-8A14BF54-FE81-446A-B20A-13E59ACEB856Q36988250-431D70AA-CBC3-4B50-B6EF-E08F9FE59B92Q37167184-01CD5628-C274-45AD-8FB5-B3EDC4745B70Q37328461-827313CC-21A8-4C0B-8CC6-766E0C287CD7Q37697685-0003E7B4-939E-478D-8B00-DEBE6BE58574Q37715489-ED1B663D-2837-4977-87F3-C9F97D5A80BAQ38037185-0E7C03E5-D85F-4D2B-9FB7-60226AB5F511Q38824445-C090255F-0136-4898-95F7-0998FD2AC49CQ38856511-83F99D4E-68A5-4F3C-9C7B-2E62819FBD3EQ40090125-D4BC487D-2A51-4761-8744-81DEAE49C978Q40428320-2EBFF440-352B-4283-9044-27763C472AE7Q40642211-C92EDA4C-D839-4FC9-B287-20349A38E3F0Q41109188-A25F8CD5-31FD-4F3F-80AA-71A8437717E6Q41881618-102BB3DA-AFDD-40BE-8CD6-A613B193A44DQ42439863-23DC9BAB-55DA-46E2-AF20-4A6CA5C898E3Q42444853-9B29F0EA-1A40-4521-BCD8-056D97382B20Q47164880-E1FA4A66-E5DF-41D9-BA28-5C7A49D6DF94Q47635650-FCA06A8A-9FD5-4385-81C7-15466EC87CCCQ49385822-6EFD0B9F-728F-4695-AA25-EC050401A694Q50528333-C1430092-C268-4825-A754-606F2A65E573Q51468976-DC3D995D-DBBF-40AF-B32A-89D1FAB4F57FQ55077069-CB0677F1-1821-4560-BA1E-48C348401B22
P2860
CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CXCR4 expression determines fu ...... ularization in acute ischemia.
@ast
CXCR4 expression determines fu ...... ularization in acute ischemia.
@en
type
label
CXCR4 expression determines fu ...... ularization in acute ischemia.
@ast
CXCR4 expression determines fu ...... ularization in acute ischemia.
@en
prefLabel
CXCR4 expression determines fu ...... ularization in acute ischemia.
@ast
CXCR4 expression determines fu ...... ularization in acute ischemia.
@en
P2093
P1476
CXCR4 expression determines fu ...... ularization in acute ischemia.
@en
P2093
Florian H Seeger
Henrik Fox
Masamichi Koyanagi
Tina Rasper
P304
P356
10.1161/ATVBAHA.109.194688
P407
P577
2009-08-20T00:00:00Z